2009
DOI: 10.1620/tjem.217.223
|View full text |Cite
|
Sign up to set email alerts
|

Bach1 Deficiency Ameliorates Hepatic Injury in a Mouse Model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 50 publications
1
16
0
Order By: Relevance
“…We need to examine whether Bach1 deficiency modulates ROS metabolism when mice are challenged with oxidative stress. The results suggest that a targeting of Bach1 in medical treatment is acceptable for acute and chronic injuries without any long-term side effect as shown in several papers [1, 26, 28, 29, 31, 45]. …”
Section: Resultsmentioning
confidence: 55%
See 1 more Smart Citation
“…We need to examine whether Bach1 deficiency modulates ROS metabolism when mice are challenged with oxidative stress. The results suggest that a targeting of Bach1 in medical treatment is acceptable for acute and chronic injuries without any long-term side effect as shown in several papers [1, 26, 28, 29, 31, 45]. …”
Section: Resultsmentioning
confidence: 55%
“…Despite the growing number of evidences that inhibition of Bach1 may be beneficial in certain clinical situations [1, 26, 28, 29, 31, 45], the long-term, organismal response to Bach1 ablation has not yet been examined. Considering its distinct effects on ROS homeostasis and cell proliferation, Bach1 deficiency may affect the aging and/or life span in mice under normal conditions; ROS levels would decrease via the derepression of HO-1, and/or the p53-dependent cellular senescence would be increased by the enhanced activity of p53.…”
Section: Introductionmentioning
confidence: 99%
“…Although advances toward understanding the involvement of Bach1 in cytoprotection during liver and myocardial ischemia have been made, 40,41 the biologic role of the CNC member Bach1 is still largely unknown. Here, we show that, in addition to Bach1-mediated normal programming of APC development, it plays a role in generating optimal immunity and autoimmune-related pathology.…”
Section: Discussionmentioning
confidence: 99%
“…system/organ effects of Bach1-deficiency references blood vessel reduction of cuff injyury with reduced smooth muscle proliferation (Omura et al, 2005) reduction in atherosclerosis in Apo E kockout mice ) heart reduction in I/R injury (Yano et al, 2006) reduced hypertrophy after pressure overload lung reduced damages after high oxygen exposure (Tanimoto et al, 2009) intestine reduced injury in small intestine after indomethacin administration (Harusato et al, 2011;Harusato et al, 2009) reduction in trinitrobenzene sulfonic acid (TNBS)-induced colitis (Harusato et al, 2013) liver reduction in steatohepatitis induced by methionine-choline deficient diet reduced damages induced by D-galactosamine and lipopolysaccharide (Iida et al, 2009) pancreas reduction of apoptosis of beta cells and less increase of blood glucose upon alloxan treatment (Kondo et al, 2013) intervertebral disc reduced damages in annulus puncture model (Ochiai et al, 2008) spinal cord reduced damages after mechanical injury and better locomoter activity (Kanno et al, 2009;Yamada et al, 2008) type mice and reduced areas of infarction after I/R (Yano et al 2006). Cardiac hypertrophy is a compensatory mechanism of the heart that functions to maintain cardiac output in the presence of sustained increases in the hemodynamic load, although it can lead to the development of cardiac failure.…”
Section: Bach1 As a Potential Therapeutic Target In Oxidative Stressrmentioning
confidence: 99%
“…In this model, Bach1-deficient mice exhibit negligible amounts of hepatic steatosis compared to the pronounced steatohepatitis observed in wild-type mice . Liver injury induced by the combination of D-galactosamine (GalN) and lipopolysaccharide (LPS) has also been reported to be reduced in Bach1-deficient mice (Iida et al 2009). …”
Section: Bach1 As a Potential Therapeutic Target In Oxidative Stressrmentioning
confidence: 99%